For decades, women navigating the physical and emotional aftermath of a mastectomy have been presented with a...
The biopharmaceutical landscape underwent a series of seismic shifts this week, characterized by intense scrutiny of high-profile...
The landscape of preclinical research is undergoing a profound metamorphosis. For decades, the paradigm of drug discovery...
NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, a poignant, multicolored glow...
The relationship between the United States—a founding member and historically the largest donor to the World Health...
Oklahoma City, OK – In a groundbreaking discovery that redefines our understanding of cancer progression, new research...
California-based biopharma company Alumis is poised to launch a significant challenge in the highly competitive oral psoriasis...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-Like Peptide-1 (GLP-1)...
The campaign arrives at a critical juncture in oncology. While advancements in screening have improved survival rates...
The landscape of oncology is undergoing a transformative shift as the U.S. Food and Drug Administration (FDA)...
